Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @EASDelearning
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @EASDelearning
-
Prikvačeni tweet
Our e-learning courses help healthcare professionals keep their knowledge of
#diabetes treatment and management up to date, with modules featuring experts in their fields. Sign up now for a free account: https://easd-elearning.org/#eLearningHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Watch Professor Mikael Knip of
@helsinkiuni introduce our course on the incidence and diagnosis of type 1#diabetes. It’s free to sign up for an account.#T1D https://easd-elearning.org/lessons/incidence-and-diagnosis-of-type-1-diabetes/ …pic.twitter.com/UEzSPB4ZFCHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EASDelearning proslijedio/la je Tweet
If you would like information on accessing
#type1 technology such as pumps, continuous glucose monitors & flash glucose monitors, visit#JDRF’s Treatments and Technologies information page or contact@INPUTdiabetes.#type1tech#gbdoc#type1diabetesPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Test your knowledge on treatment and management of diabetic foot disease with our
#eLearning module. It’s free to sign up for an account.#Diabetes https://easd-elearning.org/courses/diabetic-foot/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our
#eLearning course on cardiovascular health covers historic and contemporary study data and what this can tell us about cardiovascular risk for people with#diabetes. Sign up for a free account. https://easd-elearning.org/courses/cardiovascular-health-and-diabetes/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EASDelearning proslijedio/la je Tweet
Book now for SAHF & DaR 4th Annual Diabetes in Ramadan conference in London, Thursday 5th March: http://bit.ly/36uzLYM
@kamleshkhunti@docwas@drpratikc@AliRacaniere@ShivaniM_KC@m_alikaramat@AmarPut@amibanerjee1@AbdTahrani@KamranAbbasi@drnkan@parthaskar@DiabetesUKpic.twitter.com/PjTO1sKSr2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EASDelearning proslijedio/la je Tweet
To help
@NHSDiabetesProg deliver the next phase of#Technology access in#T1D Specialist centres: please fill in the questionnaire sent There will be provision of education: Via online modules/ face to face education days/ reading material@DTN_UK@TIME_research@NHSEnglandhttps://twitter.com/parthaskar/status/1224784635378442241 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EASDelearning proslijedio/la je Tweet
How do variations in access to
#type1diabetes technology make you feel? Learn more about the findings in JDRF's new report: http://bit.ly/JDRFPathwaytoChoice …#PathwayToChoice#type1techpic.twitter.com/avHcut48Qv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EASDelearning proslijedio/la je Tweet
#Reminder#DEUCG2020Berlin First Phase of#callforabstracts ending soon so don't forget to get your abstracts in! Visit: https://diabetes.universeconferences.com/submit-abstract/ …#Diabetes#Endocrinology#prediabetes#gestationaldiabetes#diabetesinsipidus#Diabetologist#T1D#Endocrinologist#medical#clinicalpic.twitter.com/LD2E6jamxK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EASDelearning proslijedio/la je Tweet
NEWS!!!! Oral Semaglutide (
#rybelsus)gets the green light for Europe (including U.K.) for treatment of "insufficiently controlled#type2diabetes to improve glycaemic control."https://www.novonordisk.com/media/news-details.2239245.html …@kamleshkhunti@EASDelearning@AmarPut@AbdTahrani@DSNforumUK@HPILLminsterHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Check your knowledge on the management of hyperglycaemia in type 2
#diabetes with our#eLearning module on the@AmDiabetesAssn /@EASDnews consensus report, now with 2019 update.#T2D https://easd-elearning.org/courses/management-of-hyperglycaemia-in-type-2-diabetes-2018/ …pic.twitter.com/qS7uNxvAM9Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EASDelearning proslijedio/la je Tweet
https://link.springer.com/article/10.1007/s11892-020-1291-6 … Learnt so much writing this article about the gaps in risk assesment and care models for managing diabetes and cardiovascular disease in south asians
@ArodaMd@dukeendocrinol1@DukeCardiology@DCRINewsPrikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ramadan begins in April 2020. This
#eLearning module helps you support patients with#diabetes who are fasting during the Holy month. It’s free to sign up for an account. https://easd-elearning.org/courses/diabetes-and-ramadan/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our
#eLearning platform has been designed with international experts in the field, using innovative multimedia and challenging knowledge checks to help you to learn more about the fast-moving area of#diabetes. Sign up now for a free account.#T1D#T2D https://easd-elearning.org/ pic.twitter.com/yJoLCHg9eK
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EASDelearning proslijedio/la je Tweet
Our 2020 Standards of Care includes updates from our recent consensus report w/
@EASDnews on the mgmt. of hyperglycemia in people w/#T2D. Read the report: https://bit.ly/2RHva00 pic.twitter.com/RbR7J0owub
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our
#eLearning course on cardiovascular health and#diabetes covers this important aspect of management for type 1 and type 2 diabetes. Sign up now for a free account.#T1D#T2D https://easd-elearning.org/courses/cardiovascular-health-and-diabetes/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EASDelearning proslijedio/la je Tweet
In T1 diabetes, short-term glycemic variability explains more hypoglycemia than does mean glucose https://care.diabetesjournals.org/content/early/2020/01/23/dc19-1549.abstract?papetoc …
@DSNforumUK@youngdiab@ABCDiab@AmarPut@AbdTahrani@drpatrickholmes@redGDPS@parthaskar@drpratikc@LDC_tweets@ADA_DiabetesProHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Do you know your Five Finger Rule when it comes to treating Diabetic Kidney Disease? Test your knowledge with our
#eLearning course covering#diabetes and the kidney. It’s free to sign up for an account. https://easd-elearning.org/courses/diabetes_and_the_kidney/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EASDelearning proslijedio/la je Tweet
The umbrella review that is relevant to our commentary in the
@TheLancetEndo . It has the limitations that are usual to umbrella reviews, but the advantage of including old as well as new glucose lowering agents. Interesting findings. T2#diabeteshttps://twitter.com/TheLancetEndo/status/1222782035602952192 …
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
EASDelearning proslijedio/la je Tweet
#Latest Comment: Srikanth Bellary, Abd Tahrani & Anthony Barnett on: Evidence-based prescribing of#diabetes medications: are we getting closer? https://bit.ly/2OqllD1 pic.twitter.com/zMYrfir8XY
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Check your knowledge with our
#eLearning module covering the renal outcomes of major SGLT-2 trials, with particular emphasis on the results of the CREDENCE trial. Sign up now for a free account.#Diabetes#T2D https://easd-elearning.org/lessons/module-5-renal-outcomes/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
by